MicroRNAs also enter the regulatory circuitry: serum and endothelial miR-574-5p levels are elevated in CAD, and miR-574-5p overexpression fosters vascularsmoothmusclecell proliferation while inhibiting apoptosis by silencing ZDHHC14, nominating miR-574-5p as a putative molecular target in CAD therapy [186]. Here, ZDHHC14 is linked to coronary artery disorder.